Recombinant Human Serpin B3/SSCA1 Protein, CF

R&D Systems | Catalog # 6528-PI

R&D Systems
Loading...

Key Product Details

  • R&D Systems Sf 21 (baculovirus)-derived Recombinant Human Serpin B3/SSCA1 Protein (6528-PI)
  • Quality control testing to verify active proteins with lot specific assays by in-house scientists
  • All R&D Systems proteins are covered with a 100% guarantee

Source

Sf 21 (baculovirus)

Accession Number

Applications

Enzyme Activity
Loading...

Product Specifications

Source

Spodoptera frugiperda, Sf 21 (baculovirus)-derived human Serpin B3/SCCA1 protein
Asn2-Pro390, with an N-terminal Met and 6-His tag

Purity

>95%, by SDS-PAGE under reducing conditions and visualized by Colloidal Coomassie® Blue stain at 5 μg per lane.

Endotoxin Level

<1.0 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Met

Predicted Molecular Mass

45 kDa

SDS-PAGE

40-43 kDa, reducing conditions

Activity

Measured by its ability to inhibit active Cathepsin L cleavage of a fluorogenic peptide substrate Z-LR-AMC (Catalog # ES008).
The IC50 is <5 nM, as measured under the described conditions.

Formulation, Preparation, and Storage

6528-PI
Formulation Supplied as a 0.2 μm filtered solution in Tris, NaCl and Glycerol.
Shipping The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
  • 6 months from date of receipt, -20 to -70 °C as supplied.
  • 3 months, -20 to -70 °C under sterile conditions after opening.

Background: Serpin B3/SCCA1

Serpin B3, also known as squamous cell carcinoma antigen-1 (SCCA-1), is a member of the serpin superfamily of serine protease inhibitors (1). Serpins primarily inhibit serine proteases and some are known to inhibit caspases and papain-like cysteine proteases (1). Serpin B3 belongs to the subgroup ovalbumin-related serpins which are involved in the regulation of apoptosis, inflammation, angiogenesis and embryogenesis (2). Serpin B3 was initially isolated from human cervical squamous cell tissue. It is a tumor marker for squamous cell carcinomas in various areas including the cervix, head, neck and lung (3). Unlike typical serpins, Serpin B3 shows inhibitory activity against papain-like lysosomal cysteine proteases Cathepsin K, L, and S, while lacking inhibitory activity against serine proteases (4).

References

  1. Law, R. et al. (2006) Genome Biol. 7:216.
  2. Benarafa, C. and Remold-O’Donnell, E. (2005) Proc. Natl. Acad. Sci. 102:11367.
  3. Higgens, W.J. et al. (2010) J. Biol. Chem. 285:3722.
  4. Schick, C. et al. (1998) Biochemistry. 37:5258.

Alternate Names

SCCA1, T4-A

Entrez Gene IDs

6317 (Human)

Gene Symbol

SERPINB3

UniProt

Additional Serpin B3/SCCA1 Products

Product Documents for Recombinant Human Serpin B3/SSCA1 Protein, CF

Certificate of Analysis

To download a Certificate of Analysis, please enter a lot or batch number in the search box below.

Note: Certificate of Analysis not available for kit components.

Product Specific Notices for Recombinant Human Serpin B3/SSCA1 Protein, CF

For research use only

Related Research Areas

Citations for Recombinant Human Serpin B3/SSCA1 Protein, CF

Customer Reviews for Recombinant Human Serpin B3/SSCA1 Protein, CF

There are currently no reviews for this product. Be the first to review Recombinant Human Serpin B3/SSCA1 Protein, CF and earn rewards!

Have you used Recombinant Human Serpin B3/SSCA1 Protein, CF?

Submit a review and receive an Amazon gift card!

$25/€18/£15/$25CAN/¥2500 Yen for a review with an image

$10/€7/£6/$10CAN/¥1110 Yen for a review without an image

Submit a review
Amazon Gift Card

Protocols

View specific protocols for Recombinant Human Serpin B3/SSCA1 Protein, CF (6528-PI):

Materials
  • Assay Buffer: 50 mM MES, 5 mM DTT, pH 6.0
  • Recombinant Human Serpin B3/SCCA1  (rhSerpin B3) (Catalog # 6528-PI)
  • Recombinant Human Cathepsin L (rhCathepsin L) (Catalog # 952-CY)
  • Substrate: Z-Leu-Arg-AMC (Catalog # ES008)
  • F16 Black Maxisorp Plate (Nunc, Catalog # 475515)
  • Fluorescent Plate Reader (Model: Gemini EM by Molecular Devices) or equivalent
  1. Dilute rhCathepsin L to 40 µg/mL in Assay Buffer.
  2. Incubate 40 µg/mL rhCathepsin L for 15 minutes on ice to activate.
  3. Dilute activated rhCathepsin L to 0.2 µg/mL in Assay Buffer.
  4. Prepare a curve of rhSerpin B3 (MW = 45386 Da) in Assay Buffer. Make the following serial dilutions: 1000, 200, 50, 35, 25, 15, 5, 2 and 1 nM.
  5. Combine 25 µL of each dilution with 25 µL of the 0.2 µg/mL rhCathepsin L. Include an enzyme control containing Assay Buffer in place of rhSerpin B3.
  6. Incubate reaction mixtures at 37 °C for 15 minutes.
  7. Dilute reactions by adding 200 µL Assay Buffer to each.
  8. Dilute Substrate to 20 µM in Assay Buffer.
  9. Load into a black well plate 50 µL of the diluted incubated mixtures and start the reaction by adding 50 µL substrate.
  10. Read at excitation and emission wavelengths of 380 nm and 460 nM (top read), respectively, in kinetic mode for 5 minutes.
  11. Derive the 50% inhibition concentration (IC50) value for rhSerpin B3 by plotting RFU/min vs. concentration with 4-PL fitting.
  12. Calculate the specific activity for rhCathepsin L at each point using the following formula (if needed):

     Specific Activity (pmol/min/µg) =

Adjusted Vmax* (RFU/min) x Conversion Factor** (pmol/RFU)
amount of enzyme (µg)

     *Adjusted for Substrate Blank
     **Derived using calibration standard 7-amino, 4-Methyl Coumarin (Sigma, Catalog # A-9891).

Per Well:

  • rhCathepsin L: 0.001 µg
  • rhSerpin B3: 50, 10, 2.5, 1.75, 1.25, 0.75, 0.25, 0.1, and 0.05 nM
  • Substrate: 10 μM

FAQs

No product specific FAQs exist for this product.

View all FAQs for Proteins and Enzymes
Loading...